A BILL 
To require the Secretary of Veterans Affairs to submit to 
Congress reports on patient safety and quality of care 
at medical centers of the Department of Veterans Af-
fairs, and for other purposes. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘Improving Safety and 
4
Security for Veterans Act of 2020’’. 
5
22:34 Jan 16, 2020
H5616
2 
•HR 5616 IH
SEC. 2. DEPARTMENT OF VETERANS AFFAIRS REPORTS ON 
1
PATIENT SAFETY AND QUALITY OF CARE. 
2
(a) REPORT ON PATIENT SAFETY AND QUALITY OF 
3
CARE.— 
4
(1) IN GENERAL.—Not later than 30 days after 
5
the date of the enactment of this Act, the Secretary 
6
of Veterans Affairs shall submit to the Committee 
7
on Veterans’ Affairs of the Senate and the Com-
8
mittee on Veterans’ Affairs of the House of Rep-
9
resentatives a report regarding the policies and pro-
10
cedures of the Department relating to patient safety 
11
and quality of care and the steps that the Depart-
12
ment has taken to make improvements in patient 
13
safety and quality of care at medical centers of the 
14
Department. 
15
(2) ELEMENTS.—The report required by para-
16
graph (1) shall include the following: 
17
(A) A description of the policies and proce-
18
dures of the Department and improvements 
19
made by the Department with respect to the 
20
following: 
21
(i) How often the Department reviews 
22
or inspects patient safety at medical cen-
23
ters of the Department. 
24
22:34 Jan 16, 2020
H5616
3 
•HR 5616 IH
(ii) What triggers the aggregated re-
1
view process at medical centers of the De-
2
partment. 
3
(iii) What controls the Department 
4
has in place for controlled and other high- 
5
risk substances, including the following: 
6
(I) Access to such substances by 
7
staff. 
8
(II) What medications are dis-
9
pensed via automation. 
10
(III) What systems are in place 
11
to ensure proper matching of the cor-
12
rect medication to the correct patient. 
13
(IV) Controls of items such as 
14
medication carts and pill bottles and 
15
vials. 
16
(V) Monitoring of the dispensing 
17
of medication within medical centers 
18
of the Department, including moni-
19
toring of unauthorized dispensing. 
20
(iv) How the Department monitors 
21
contact between patients and employees of 
22
the Department, including how employees 
23
are monitored and tracked at medical cen-
24
22:34 Jan 16, 2020
H5616
4 
•HR 5616 IH
ters of the Department when entering and 
1
exiting the room of a patient. 
2
(v) How comprehensively the Depart-
3
ment uses video monitoring systems in 
4
medical centers of the Department to en-
5
hance patient safety, security, and quality 
6
of care. 
7
(vi) How the Department tracks and 
8
reports deaths at medical centers of the 
9
Department at the local level, Veterans In-
10
tegrated Service Network level, and na-
11
tional level. 
12
(vii) The procedures of the Depart-
13
ment to alert local, regional, and Depart-
14
ment-wide leadership when there is a sta-
15
tistically abnormal number of deaths at a 
16
medical center of the Department, includ-
17
ing— 
18
(I) the manner and frequency in 
19
which such alerts are made; and 
20
(II) what is included in such an 
21
alert, such as the nature of death and 
22
where within the medical center the 
23
death occurred. 
24
22:34 Jan 16, 2020
H5616
5 
•HR 5616 IH
(viii) The use of root cause analyses 
1
with respect to patient deaths in medical 
2
centers of the Department, including— 
3
(I) what threshold triggers a root 
4
cause analysis for a patient death; 
5
(II) who conducts the root cause 
6
analysis; and 
7
(III) how root cause analyses de-
8
termine whether a patient death is 
9
suspicious or not. 
10
(ix) What triggers a patient safety 
11
alert, including how many suspicious 
12
deaths cause a patient safety alert to be 
13
triggered. 
14
(x) The situations in which an au-
15
topsy report is ordered for deaths at hos-
16
pitals of the Department, including an 
17
identification of— 
18
(I) when the medical examiner is 
19
called to review a patient death; and 
20
(II) the official or officials that 
21
decide such a review is necessary. 
22
(xi) The method for family members 
23
of a patient who died at a medical center 
24
22:34 Jan 16, 2020
H5616
6 
•HR 5616 IH
of the Department to request an investiga-
1
tion into that death. 
2
(xii) The opportunities that exist for 
3
family members of a patient who died at a 
4
medical center of the Department to re-
5
quest an autopsy for that death. 
6
(xiii) The methods in place for em-
7
ployees of the Department to report sus-
8
picious deaths at medical centers of the 
9
Department. 
10
(xiv) The steps taken by the Depart-
11
ment if an employee of the Department is 
12
suspected to be implicated in a suspicious 
13
death at a medical center of the Depart-
14
ment, including— 
15
(I) actions to remove or suspend 
16
that individual from patient care or 
17
temporarily reassign that individual 
18
and the speed at which that action oc-
19
curs; and 
20
(II) steps taken to ensure that 
21
other medical centers of the Depart-
22
ment and other non-Department med-
23
ical centers are aware of the suspected 
24
22:34 Jan 16, 2020
H5616
7 
•HR 5616 IH
role of the individual in a suspicious 
1
death. 
2
(xv) In the case of the suspicious 
3
death of an individual while under care at 
4
a medical center of the Department, the 
5
methods used by the Department to inform 
6
the family members of that individual. 
7
(xvi) The policy of the Department for 
8
communicating to the public when a sus-
9
picious death occurs at a medical center of 
10
the Department. 
11
(B) A description of any additional au-
12
thorities or resources needed from Congress to 
13
implement any of the actions, changes to policy, 
14
or other matters included in the report required 
15
under paragraph (1). 
16
(b) REPORT ON DEATHS AT LOUIS A. JOHNSON 
17
MEDICAL CENTER.— 
18
(1) IN GENERAL.—Not later than 60 days after 
19
the date on which the Attorney General indicates 
20
that any investigation or trial related to the sus-
21
picious deaths of veterans at the Louis A. Johnson 
22
VA Medical Center in Clarksburg, West Virginia (in 
23
this subsection referred to as the ‘‘Facility’’), that 
24
occurred during 2017 and 2018 has sufficiently con-
25
22:34 Jan 16, 2020
H5616
8 
•HR 5616 IH
cluded, the Secretary of Veterans Affairs shall sub-
1
mit to the Committee on Veterans’ Affairs of the 
2
Senate and the Committee on Veterans’ Affairs of 
3
the House of Representatives a report describing— 
4
(A) the events that occurred during that 
5
period related to those suspicious deaths; and 
6
(B) actions taken at the Facility and 
7
throughout the Department of Veterans Affairs 
8
to prevent any similar reoccurrence of the 
9
issues that contributed to those suspicious 
10
deaths. 
11
(2) ELEMENTS.—The report required by para-
12
graph (1) shall include the following: 
13
(A) A timeline of events that occurred at 
14
the Facility relating to the suspicious deaths 
15
described in paragraph (1) beginning the mo-
16
ment those deaths were first determined to be 
17
suspicious, including any notifications to— 
18
(i) leadership of the Facility; 
19
(ii) leadership of the Veterans Inte-
20
grated Service Network in which the Facil-
21
ity is located; 
22
(iii) leadership at the central office of 
23
the Department; and 
24
22:34 Jan 16, 2020
H5616
9 
•HR 5616 IH
(iv) the Office of the Inspector Gen-
1
eral of the Department of Veterans Af-
2
fairs. 
3
(B) A description of the actions taken by 
4
leadership of the Facility, the Veterans Inte-
5
grated Service Network in which the Facility is 
6
located, and the central office of the Depart-
7
ment in response to the suspicious deaths, in-
8
cluding responses to notifications under sub-
9
paragraph (A). 
10
(C) A description of the actions, including 
11
root cause analyses, autopsies, or other activi-
12
ties that were conducted after each of the sus-
13
picious deaths. 
14
(D) A description of the changes made by 
15
the Department since the suspicious deaths to 
16
procedures to control access within medical cen-
17
ters of the Department to controlled and non- 
18
controlled substances to prevent harm to pa-
19
tients. 
20
(E) A description of the changes made by 
21
the Department to its nationwide controlled 
22
substance and non-controlled substance policies 
23
as a result of the suspicious deaths. 
24
22:34 Jan 16, 2020
H5616
10 
•HR 5616 IH
(F) A description of the changes planned 
1
or made by the Department to its video surveil-
2
lance at medical centers of the Department to 
3
improve patient safety and quality of care in re-
4
sponse to the suspicious deaths. 
5
(G) An analysis of the review of sentinel 
6
events conducted at the Facility in response to 
7
the suspicious deaths and whether that review 
8
was conducted consistent with policies and pro-
9
cedures of the Department. 
10
(H) A description of the steps the Depart-
11
ment has taken or will take to improve the 
12
monitoring of the credentials of employees of 
13
the Department to ensure the validity of those 
14
credentials, including all employees that inter-
15
act with patients in the provision of medical 
16
care. 
17
(I) A description of the steps the Depart-
18
ment has taken or will take to monitor and 
19
mitigate the behavior of employee bad actors, 
20
including those who attempt to conceal their 
21
mistreatment of veteran patients. 
22
(J) A description of the steps the Depart-
23
ment has taken or will take to enhance or cre-
24
ate new monitoring systems that— 
25
22:34 Jan 16, 2020
H5616
11 
•HR 5616 IH
(i) automatically collect and analyze 
1
data from medical centers of the Depart-
2
ment and monitor for warning signs or un-
3
usual health patterns that may indicate a 
4
health safety or quality problem at a par-
5
ticular medical center; and 
6
(ii) automatically share those warn-
7
ings with other medical centers of the De-
8
partment, relevant Veterans Integrated 
9
Service Networks, and officials of the cen-
10
tral office of the Department. 
11
(K) A description of the accountability ac-
12
tions that have been taken at the Facility to re-
13
move or discipline employees who significantly 
14
participated in the actions that contributed to 
15
the suspicious deaths. 
16
(L) A description of the system-wide re-
17
porting process that the Department will or has 
18
implemented to ensure that relevant employees 
19
are properly reported, when applicable, to the 
20
National Practitioner Data Bank of the Depart-
21
ment of Health and Human Services, the appli-
22
cable State licensing boards, the Drug Enforce-
23
ment Administration, and other relevant enti-
24
ties. 
25
22:34 Jan 16, 2020
H5616
12 
•HR 5616 IH
(M) A description of any additional au-
1
thorities or resources needed from Congress to 
2
implement any of the recommendations or find-
3
ings included in the report required under para-
4
graph (1). 
5
(N) Such other matters as the Secretary 
6
considers necessary. 
7
Æ 
22:34 Jan 16, 2020
H5616
